Cargando…
Effect of Gastrointestinal Symptoms in Patients With COVID-19
Autores principales: | Zhou, Zili, Zhao, Ning, Shu, Yan, Han, Shengbo, Chen, Bin, Shu, Xiaogang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270807/ https://www.ncbi.nlm.nih.gov/pubmed/32199880 http://dx.doi.org/10.1053/j.gastro.2020.03.020 |
Ejemplares similares
-
COVID-19 in Latin America: Symptoms, Morbidities, and Gastrointestinal Manifestations
por: Ashktorab, Hassan, et al.
Publicado: (2021) -
Associations Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blocker Use, Gastrointestinal Symptoms, and Mortality Among Patients With COVID-19
por: Tan, Nian-Di, et al.
Publicado: (2020) -
COVID-19 Pediatric Patients: Gastrointestinal Symptoms, Presentations, and Disparities by Race/Ethnicity in a Large, Multicenter US Study
por: Ashktorab, Yusuf, et al.
Publicado: (2021) -
Stress-induced epinephrine promotes epithelial-to-mesenchymal transition and stemness of CRC through the CEBPB/TRIM2/P53 axis
por: Zhou, Zili, et al.
Publicado: (2022) -
Increasing rate of hospitalization for severe peptic ulcer in digestive disease emergencies after the pandemic
por: Jian, Chenxing, et al.
Publicado: (2022)